Epstein-linked longevity expert Peter Attia is leaving David Broten, and his startup would not comment

Founder of David Protein, maker of popular protein bars, Announce On Monday, longevity expert Dr Peter Attia resigned from his position as David’s chief science officer.

The announcement comes after Attia’s name appeared in more than 1,700 documents, including email correspondence, released on Friday as part of a massive dossier relating to convicted sex offender Jeffrey Epstein. According to the New York Times. Attia worked on the executive team of the food startup and was also a member of the team Early investor.

For those who don’t know him, Attia is a Canadian-American physician who has become one of the most prominent voices in the field of longevity and preventive health. He is best known for his best-selling book “Outlive: The Science and Art of Longevity” and his now seven-year-old podcast, where he explores improvement strategies. He was also named last month as a CBS contributor.

Three-year-old New York-based David Protein raised a $75 million Series A funding round in May last year led by Greenoaks, with participation from Valor Equity Partners. The company has seen significant growth since launching its flagship protein bar in September 2024, a product it describes as having 28 grams of protein, zero sugar and 150 calories.

In a long time Share on XAttiya wrote that he was “ashamed” by some of the crude content in his emails with Epstein, but also said he was not involved in criminal activity and had never visited Epstein’s island or traveled on his plane. Attia also discussed at length how he came to know Epstein and why he remained involved with him even after Epstein 2008 conviction.

The ramifications appear to extend beyond David’s protein. It also appears that Biograph, the healthcare and longevity testing startup that Attia co-founded with entrepreneur John Herring, may be distancing itself from the doctor. The company declined to comment on Attia’s continued involvement with the startup or on the pages on its website that used to mention him but now delete his name or display a “File not found” error.

The CV came out of hiding a year ago. I mentioned TechCrunch previouslybacked by investors including Vy Capital, Human Capital, Alpha Wave and WndrCo, along with angel investors including Balaji Srinivasan. Like a growing number of medical services companies, Biograph offers premium preventive health services to subscribers who pay between $7,500 and $15,000 annually. Attia was previously named on Company press release And the site as a co-founder.